CLBT Cellebrite DI Ltd

  1. Stocks
  2. Technology
  3. NASDAQ: CLBT

Price (delayed)

$14.39

Market cap

$3.55B

P/E Ratio

51.39

Dividend/share

N/A

EPS

$0.28

Enterprise value

$3.44B

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 32
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 95

Cellebrite is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and ...

Highlights
The equity is up by 40% year-on-year and by 5% since the previous quarter
The gross profit has increased by 18% YoY and by 4% QoQ
The net income has surged by 137% year-on-year but it has declined by 8% since the previous quarter
Cellebrite DI's EPS has surged by 131% YoY but it has decreased by 13% QoQ
The debt has soared by 115% YoY
The quick ratio has contracted by 16% YoY and by 2.7% from the previous quarter
Sector: Technology
Industry: Software - Infrastructure
Website: https://www.cellebrite.com
Peers: PHR PHUN

Key stats

What are the main financial stats of CLBT

CLBT stock price

How has the Cellebrite DI stock price performed over time
Intraday
1.48%
1 week
9.02%
1 month
5.5%
1 year
-13.63%
YTD
-20.19%
QTD
4.43%

Financial performance

How have Cellebrite DI's revenue and profit performed over time
Revenue
$496.43M
Gross profit
$416.33M
Operating income
$63.33M
Net income
$71.86M
Gross margin
83.9%
Net margin
14.5%
The net income has surged by 137% year-on-year but it has declined by 8% since the previous quarter
The net margin has soared by 131% YoY but it has contracted by 12% from the previous quarter
The gross profit has increased by 18% YoY and by 4% QoQ
CLBT's revenue is up by 18% YoY and by 4.4% QoQ

Price vs fundamentals

How does CLBT's price correlate with its fundamentals

Growth

What is Cellebrite DI's growth rate over time

Valuation

What is Cellebrite DI stock price valuation
P/E
51.39
P/B
7.03
P/S
7.14
EV/EBIT
54.25
EV/EBITDA
43.18
EV/Sales
6.92
Cellebrite DI's EPS has surged by 131% YoY but it has decreased by 13% QoQ
The equity is up by 40% year-on-year and by 5% since the previous quarter
The stock's price to book (P/B) is 21% less than its last 4 quarters average of 8.8
The P/S is 19% below the last 4 quarters average of 8.7 but 10% above the 5-year quarterly average of 6.4
CLBT's revenue is up by 18% YoY and by 4.4% QoQ

Efficiency

How efficient is Cellebrite DI business performance
CLBT's return on assets has surged by 127% year-on-year but it is down by 15% since the previous quarter
CLBT's ROE has soared by 119% YoY but it is down by 16% from the previous quarter
CLBT's return on invested capital is down by 10% year-on-year
Cellebrite DI's return on sales has decreased by 10% YoY and by 9% QoQ

Dividends

What is CLBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLBT.

Financial health

How did Cellebrite DI financials performed over time
The total assets is 116% more than the total liabilities
The total assets has grown by 34% YoY
Cellebrite DI's total liabilities has increased by 28% YoY but it has decreased by 2.8% from the previous quarter
The debt is 96% less than the equity
The debt has soared by 115% YoY
The equity is up by 40% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.